Renagel® phosphorus binder for dialysis patients replaced by newer version of the drug

The pharmaceutical company Genzyme announced Renagel®, a phosphate binding medication widely used throughout the US, will no longer be distributed in the US after September…

Continue Reading »

Phosphorus Binder News

This week Genzyme Corp. announced their phosphorus binding drug Renagel® is being replaced by the newer binder Renvela® in the US. The newer drug, available…

Continue Reading »